Treprostinil

5 trials 3 recruiting BHaematology Orphan designation

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

3 Recruiting

2 Completed trials

3 Sponsors

15 Countries

Phase III

Phase III/IV

Phase III: 4 Phase III/IV: 1

Indications tested

Idiopathic pulmonary fibrosis 1 Pulmonary fibrosis 1 Pulmonary arterial hypertension 1

Sponsors using this IMP

United Therapeutics Corp. 3 Aop Orphan Pharmaceuticals GmbH 1 Liquidia Technologies Inc. 1

All trials

5 total

A clinical study to test how safe and effective a new inhaled treatment (called L606) is for people with high blood pressure in the lungs du… Recruiting

2024-517943-29-00 Phase III 10 countries Liquidia Technologies Inc.
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Recruiting

2023-504904-26-00 Phase III 5 countries United Therapeutics Corp.
Randomized trial comparing efficacy and safety of initial triple therapy including parenteral treprostinil to initial double oral therapy in… Recruiting

2023-504351-26-01 Phase III/IV 12 countries Aop Orphan Pharmaceuticals GmbH
Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease Ended

2023-504471-25-00 Phase III 7 countries United Therapeutics Corp.
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Ended

2024-514761-19-00 Phase III 7 countries United Therapeutics Corp.

Showing 1–5 of 5 trials

← All drugs A–Z